Announcements

Autolus Therapeutics plc filed a Form 8-K on August 3, 2026, announcing an increase to its full-year 2026 net product revenue guidance for AUCATZYL, anticipated Q2 2026 revenue figures, gross margin expectations, a new credit facility, and an updated cash runway outlook.

Petco Health and Wellness Company, Inc. filed a current report on August 3, 2026, disclosing the resignation of director Cameron Breitner and the appointment of Jeffrey Naylor as an independent Class I director and Chair of the Audit Committee, both effective August 1, 2026.

Avidbank Holdings, Inc. (NASDAQ: AVBH) filed a current report on Form 8-K dated August 3, 2026, disclosing the appointment of Jonathan M. Dale as President of both the company and its wholly owned subsidiary, Avidbank, a California state-chartered bank headquartered in San Jose, California.

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) filed a current report on August 1, 2026, disclosing that it had entered into an Agreement and Plan of Merger with Supernus Pharmaceuticals, Inc., under which Supernus will become a wholly owned subsidiary of Indivior and the combined entity …

Indivior Pharmaceuticals, Inc. filed a Form 8-K on August 3, 2026, under Regulation FD, disclosing the execution of an Agreement and Plan of Merger dated August 1, 2026, between Indivior, Supernus Pharmaceuticals, Inc., and Artemis Merger Sub Inc., a wholly owned subsidiary of Indivior.

Warner Music Group Corp. (NASDAQ: WMG) filed a current report on August 3, 2026, disclosing preliminary unaudited financial estimates for the three months ended June 30, 2026, ahead of the completion of its formal closing procedures.

Esquire Financial Holdings, Inc. filed a Form 8-K with the SEC on August 1, 2026, reporting the completion of its merger with Signature Bancorporation, Inc. and related board and officer changes effective that same date.